Prevalence of cervical cytological abnormalities in Turkey

Tarih
2009
Yazar
Cetinarslan, Ilknur
Gokaslan, Huesnu
Eren, Funda
Celik, Cetin
Yilmaz, Osman
Celik, Huesnue
AKSAZ, Zeliha
KOCAK, Cengiz
BAGCI, Hafize
DAVUTOGLU, Bilge Sel
Hakverdi, Ali Ulvi
Soysal, Mehmet Emin
Kaya, Guelcan
Yanik, Ali
Arici, Sema
Cetin, Halit
Mutlu, Ahmet Emin
Kolusari, Ali
Kosem, Mustafa
Sahin, Guler
Demirturk, Fazli
GULTEKIN, Murat
Karaca, Mehmet
HARMA, Mehmet
HARMA, Muege
DEMIRBAG, Nilgun
Baykal, Cem
Dogan, Isin
SAM, Asli Demir
Batur, Sebnem
KARA, Fadil
ACIKALM, Arbil
Kiran, Guerkan
METINDIR, Jale
Ozan, Hakan
Ozalp, Sinan
VARDAR, MEHMET ALİ
Zeren, Handan
Dilek, Saffet
Bozkaya, Hasan
Guven, Sueleyman
Ersoz, Safak
Meydanli, Mutlu
Üst veri
Tüm öğe kaydını göster
Özet
Objective: To evaluate retrospectively the prevalence of cervical cytological abnormalities in patient records obtained from healthcare centers in Turkey. Method: Demographic characteristics and data on cervical cytological abnormalities were evaluated from patients who underwent flap tests in healthcare centers in 2007. Results: Data were collected from 33 healthcare centers totaling 140 334 patients. Overall, the prevalence of cervical cytological abnormalities was 1.8%; the prevalence of ASCUS, ASC-H, LSIL, HSIL, and AGC was 1.07%, 0.07%, 0.3%, 0.17%, and 0.08%, respectively. The prevalence of preinvasive cervical neoplasia was 1.7% and the prevalence of cytologically diagnosed invasive neoplasia was 0.06%. Conclusion: The abnormal cervical cytological prevalence rate in Turkey is lower than in Europe and North America. This might be due to sociocultural differences, lack of population-based screening programs, or a lower HPV prevalence rate in Turkey. (C) 2009 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
Bağlantı
http://hdl.handle.net/20.500.12627/13058
https://doi.org/10.1016/j.ijgo.2009.04.003
Koleksiyonlar